KRT17 and urothelial carcinoma: Recently, Babu et al. performed a study looking at K17 in urothelial carcinomas and showed that K17 is expressed in urothelial carcinomas at levels of 2.5 to 8 log fold greater than normal urothelial mucosa, making it a promising biomarker for bladder cancer.25